These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30792079)

  • 1. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs.
    Lapeyre-Mestre M; Montastruc F
    Therapie; 2019 Apr; 74(2):209-214. PubMed ID: 30792079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacovigilance - The next chapter.
    Moore N; Berdaï D; Blin P; Droz C
    Therapie; 2019 Dec; 74(6):557-567. PubMed ID: 31623850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interest of pharmacoepidemiology in pharmacovigilance: Post-authorization safety studies in regulatory pharmacovigilance activity.
    Abou Taam M; Ferard C; Rocle P; Maison P
    Therapie; 2019 Apr; 74(2):301-306. PubMed ID: 30704766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverging approaches of pharmacovigilance and pharmacoepidemiology to assessing drug safety: epistemological and ethical implications.
    Coste J
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):600-602. PubMed ID: 28239922
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
    Montastruc JL
    Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
    [No Abstract]   [Full Text] [Related]  

  • 9. A conceptual approach to the masking effect of measures of disproportionality.
    Maignen F; Hauben M; Hung E; Holle LV; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):208-17. PubMed ID: 24243699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs.
    Agustí A; Cereza G; de Abajo FJ; Maciá MA; Sacristán JA
    Pharmacol Res; 2023 Nov; 197():106967. PubMed ID: 37865127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
    Montastruc JL; Benevent J; Montastruc F; Bagheri H; Despas F; Lapeyre-Mestre M; Sommet A
    Therapie; 2019 Apr; 74(2):169-174. PubMed ID: 30389102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and pharmacovigilance of protein kinase inhibitors.
    Khouri C; Mahé J; Caquelin L; Locher C; Despas F
    Therapie; 2022; 77(2):207-217. PubMed ID: 34895753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
    Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
    Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.
    Lai EC; Pratt N; Hsieh CY; Lin SJ; Pottegård A; Roughead EE; Kao Yang YH; Hallas J
    Eur J Epidemiol; 2017 Jul; 32(7):567-582. PubMed ID: 28698923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian model selection in logistic regression for the detection of adverse drug reactions.
    Marbac M; Tubert-Bitter P; Sedki M
    Biom J; 2016 Nov; 58(6):1376-1389. PubMed ID: 27225325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics.
    Kaguelidou F; Durrieu G; Clavenna A
    Therapie; 2019 Apr; 74(2):315-324. PubMed ID: 30773345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in adverse drug reactions: Are women more impacted?
    Lacroix C; Maurier A; Largeau B; Destere A; Thillard EM; Drici M; Micallef J; Jonville-Bera AP
    Therapie; 2023; 78(2):175-188. PubMed ID: 36283857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-non-case studies: Principle, methods, bias and interpretation.
    Faillie JL
    Therapie; 2019 Apr; 74(2):225-232. PubMed ID: 30773344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.